Patent Assignment
Reel/Frame 061071/0507
Change of Name
Recorded: 2022-08-04
Pages: 4
Assignor
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Executed: 2022-04-01
Assignee
SUMITOMO PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Aminopyrimidinylaminobenzonitrile Derivatives as NEK2 Inhibitors
Application:
17/759,147 →
Publication:
US 2023/0090742
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.